Rural Intervention for Caregivers' Heart Health
- Conditions
- Cardiovascular Risk Factor
- Registration Number
- NCT03068390
- Lead Sponsor
- Debra Moser
- Brief Summary
The investigators are testing a two-group, randomized, controlled trial with 280 primary caregivers of adult patients with a chronic illness to test the efficacy of the Rural Intervention for Caregivers' Heart Health (RICHH). Immediate (4-month) and long-term (12-month) effects of the RICHH intervention on CVD risk factors, self-management behaviors, and depressive symptoms will be compared to usual care. The investigators also will test the moderating effect of gender on intervention outcomes, given the many differences between male and female caregivers.
Specific Aim 1: To determine effects of the RICHH intervention on the primary outcomes of CVD risk factors (i.e., lipid profile, body mass index, and blood pressure) at 4 and 12 months.
Hypotheses 1: The intervention group will have better lipid profile, body mass index, and blood pressure outcomes than the usual care group at 4 and 12 months.
Specific Aim 2: To determine effects of the RICHH intervention on self-management behaviors (i.e., diet quality, physical activity level, and self-report adherence to specific CVD health behaviors).
Hypotheses 2: The intervention group will have better diet quality, higher physical activity levels, and better adherence to specific CVD health behaviors than the usual care group at 4 and 12 months.
Specific Aim 3: To determine effects of RICHH on depressive symptoms at 4 and 12 months.
Hypotheses 3: Caregivers receiving the intervention will have lower levels of depressive symptoms than caregivers receiving usual care at 4 and 12 months.
Specific Aim 4: To evaluate whether intervention effects on outcomes will differ by caregivers' gender.
Hypotheses 4: Effects will be stronger for male compared to female caregivers at 4 and 12 months.
Impact: The proposed study will have a substantial impact on caregivers' cardiovascular health and quality of life because it will provide needed CVD risk prevention, and health promotion to rural caregivers living in distressed environments where CVD risk reduction and self-management is difficult. The intervention holds the potential to produce major improvements in health among caregivers living in rural environments in the US.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 311
- primary family rural caregiver of patients with chronic illnesses
- provided care for the patient for > 6 months
- no cognitive impairment that would preclude understanding the consent process
- chronic drug abuse
- current active cancer
- any physical or emotional impairment that limits participants' abilities to engage in self-management or that is likely to result in needing a caregiver in the next 12 months.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in Lipid Profile Derived from point-of-care testing Baseline, 4 and 12 months lipid profile from point-of-care testing
Change in Body Mass Index (kg/m2) calculated from height and weight Baseline, 4 and 12 months body mass index calculated from height and weight
Change in Blood Pressure in mmHg Baseline, 4 and 12 months blood pressure
- Secondary Outcome Measures
Name Time Method Change in Physical Activity Level (steps per 24 hours) measured by actigraphy Baseline, 4 and 12 months physical activity levels assessed using Withings actigraph
Change in Depressive Symptoms Baseline, 4 and 12 months depressive symptoms measured using PHQ-9
Change in Adherence measured using the Specific Adherence Scale score from Medical Outcomes Study Baseline, 4 and 12 months adherence using Specific Adherence Scale from Medical Outcomes Study
Change in Diet Quality measured by the Food Frequency Questionnaire Baseline, 4 and 12 months diet quality
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University of Kentucky
🇺🇸Lexington, Kentucky, United States
University of Kentucky🇺🇸Lexington, Kentucky, United States